openPR Logo
Press release

Ineffective Esophageal Motility Treatment Market 2022 Global Market Analysis and Forecasts to 2030

07-14-2022 07:05 PM CET | Health & Medicine

Press release from: Persistence Market Research

Ineffective Esophageal Motility Treatment Market 2022 Global

Ineffective esophageal motility treatment leads to a reduction in muscle damage and improved outcomes, improving quality of life and resulting in long-term benefits. Device-based treatment and IEMT drugs have already had a substantial impact on how symptoms of GERD and achalasia are treated.

The first and the most important factor driving the growth of the ineffective esophageal motility treatment market is the increasing prevalence of gastroesophageal reflux disease. Other factors, such as intake of asthma medications and increasing geriatric population, are also responsible for driving the ineffective esophageal motility treatment market.

How About Looking Through The Sample Of Ineffective Esophageal Motility Treatment Market Report? https://www.persistencemarketresearch.com/samples/31550

Companies covered in Ineffective Esophageal Motility Treatment Market Report

Johnson & Johnson
Mylan Pharmaceutical
MediGus Ltd.
Torax Medical
Medtronic plc.
AstraZeneca plc.
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
GlaxoSmithKline plc.
Bayer AG
Pfizer Inc.
Bausch Health Companies Inc.
LABORIE
Mederi Therapeutics, Inc.
Becton, Dickinson and Company (C. R. Bard, Inc.)
EndoGastric Solutions, Inc
Olympus
Pentax

How About Step-By-Step Insights To Ineffective Esophageal Motility Treatment Market? Look Through The "Methodology" Employed! https://www.persistencemarketresearch.com/methodology/31550

According to the latest report published by PMR, the global ineffective esophageal motility treatment market is projected to expand at a decent CAGR of around 6% during the forecast period (2020-2030).

Key Takeaways from Ineffective Esophageal Motility Treatment Market Study

Significant advantages of ineffective esophageal motility treatment; improving reimbursement scenario for surgical treatment devices; increasing awareness regarding gastric reflux disease; and large patient pool for GERD, dysphagia, achalasia, and burning chest pain are key factors propelling the growth of ineffective esophageal motility treatment market in developing regions.

North America is a prominent region the global ineffective esophageal motility treatment market, while East Asia is expected to offer lucrative growth opportunities, owing to the large population base and higher incidence of GERD and dysphagia.

Higher OTC antacid consumption is poised to drive the growth of the market.

Radiofrequency ablation systems with high level precision and procedural advantages over myotomy are expected to generate significant revenue in the long term.

Increasing adoption of ineffective esophageal motility treatment drugs for quick recovery as compared to device-based treatment marks higher revenue potential.

Raw material procurement issues, drug shortages, and reduced patient visits amidst the COVID-19 pandemic will adversely affect the growth of the ineffective esophageal motility treatment market in the near term.

"Procedural accuracy achieved by treatment devices and affordability of drug-based treatment are anticipated to drive the ineffective esophageal motility treatment market. Additionally, the large patient pool will bring in steady revenue opportunities," says a PMR analyst.

Access Full report! https://www.persistencemarketresearch.com/checkout/31550

New Product Launches by Key Players to Strengthen Market Presence

Key manufacturers in the ineffective esophageal motility treatment market are mainly focusing on research & development and introduction new & advanced treatment products. For example, LINX is the new and advanced version of the LINX reflux management device that is used for the transoral incision-less fundoplication process, which is one of the important procedures for the treatment of gastroesophageal reflux disease.

The innovation of new & advanced products is a factor boosting the ineffective esophageal motility treatment market. In addition, Olympus Corporation has launched advanced versions of esophagoscopes, which have improved the treatment curve of gastroesophageal reflux disease. Manufacturers are focusing on extended indication list and higher reimbursement to draw demand and increase profitability.

Alternatively, a key factor affecting the ineffective esophageal motility treatment market is the entry of generic drug manufacturers. Market leaders are constantly working on strengthening their strategies to gain market share.

What else is in the report?

Persistence Market Research offers a unique perspective and actionable insights on the ineffective esophageal motility treatment market in its latest study, presenting historical demand assessment of 2015-2019 and projections for 2020-2030, on the basis of product (drugs and devices), indication (GERD, dysphagia, achalasia, and burning chest pain), and end user (institutional sales and retail sales), across seven key regions.

Access PMR Exclusive Reports-

Testing Inspection And Certification Market- https://www.persistencemarketresearch.com/market-research/testing-inspection-and-certification-market.asp

8K Technology Market- https://www.persistencemarketresearch.com/market-research/8k-technology-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ineffective Esophageal Motility Treatment Market 2022 Global Market Analysis and Forecasts to 2030 here

News-ID: 2680763 • Views:

More Releases from Persistence Market Research

U.S. Dishwasher Market to Reach US$ 12.8 Billion by 2032 - Persistence Market Research
U.S. Dishwasher Market to Reach US$ 12.8 Billion by 2032 - Persistence Market Re …
The U.S. dishwasher market is entering a strong growth phase supported by evolving consumer lifestyles, technological upgrades, and rising adoption of convenience-driven home appliances. As per recent industry estimates, the market is valued at US$ 8.2 billion in 2025 and is forecasted to reach US$ 12.8 billion by 2032, advancing at a CAGR of 6.6% between 2025 and 2032. This robust trajectory underscores how households and commercial establishments are increasingly
U.S. & Canada Residential Ceiling Fan Market Set for Strong Growth Through 2032
U.S. & Canada Residential Ceiling Fan Market Set for Strong Growth Through 2032
The U.S. & Canada residential ceiling fan market is gearing up for a period of steady and promising expansion. Valued at US$5.6 billion in 2025, the market is projected to reach US$8.5 billion by 2032, driven by a healthy CAGR of 6.1% during the forecast period. With rising emphasis on energy efficiency, modern home aesthetics, and smart-home integration, ceiling fans are becoming indispensable components of residential comfort systems across North
Europe Used Car Market to Hit US$503.1 Billion by 2031 as Key Players Like Auto1 Group, Aramis Group, and Cazoo Transform Digital Retailing
Europe Used Car Market to Hit US$503.1 Billion by 2031 as Key Players Like Auto1 …
The Europe used car market is undergoing a transformational shift driven by evolving consumer preferences, rising digitalization in automotive retail, and higher demand for cost-effective mobility solutions. According to Persistence Market Research, the market is projected to reach US$503.1 billion by 2031, rising from US$341.3 billion in 2024, with a steady CAGR of 5.7% from 2024 to 2031. This growth demonstrates how significantly the market is being shaped by factors
Bike and Scooter Rental Market to Hit US$16.9 Billion by 2032 as Key Players Like Lime, Bird, and Spin Accelerate Global Expansion
Bike and Scooter Rental Market to Hit US$16.9 Billion by 2032 as Key Players Lik …
The global bike and scooter rental market is undergoing rapid transformation as urban mobility shifts toward shared, sustainable, and cost-efficient transportation solutions. According to Persistence Market Research, the market was valued at US$ 5.4 Bn in 2024 and is expected to expand from US$ 6.2 Bn in 2025 to US$ 16.9 Bn by 2032, reflecting an impressive CAGR of 15.5% between 2025 and 2032. This accelerated growth is being shaped

All 5 Releases


More Releases for Ineffective

Ineffective Esophageal Motility Treatment Market Poised for Expansion, Notes Per …
The global Ineffective Esophageal Motility (IEM) Treatment Market has entered a period of sustained growth, propelled by rising gastrointestinal disorders and increasing awareness of esophageal motility diseases. Valued at US$ 4.21 billion in 2023, the market is projected to nearly double and reach US$ 7.47 billion by 2033, expanding at a steady 5.9% CAGR. IEM, often associated with conditions such as gastroesophageal reflux disease (GERD), dysphagia, and hiatal hernia, is
Terischwartz Associates Exposes the True Cost of Ineffective Meetings in Today's …
Image: https://www.abnewswire.com/upload/2025/07/3cd3e20ec6c36670720e5834999ed2ab.jpg Executives across the country sit in boardrooms and virtual rooms alike, facing a steady stream of meetings that move agendas sideways, not forward. At the center of this epidemic lies a rarely acknowledged truth: most meetings lack a clear purpose, structure, or outcome. Despite their ubiquity, they remain one of the greatest hidden inefficiencies in modern business. Evan Unger [https://www.terischwartzassociates.com/our-team/evan-unger/], managing partner at a national leadership consulting firm, studies this
Steep learning curve and ineffective customer support keep AccountEdge second to …
Brandon, MB--May 25, 2023: AccountEdge helps small businesses establish inventory, billing, managing contacts, creating and tracking sales and purchases. It's compatible with both Mac and Windows operating systems. An on-premise and accounting management solution, it gives users the freedom to create an eCommerce platform where they can sell items online using Shopify, download orders directly to the account and synchronize the inventory items for selling. The banking tool gives
The Ineffective Esophageal Motility Treatment Market to keep pace with the lates …
The Ineffective Esophageal Motility Treatment Market is expected to witness a staggering CAGR going forward. The gamut of care is being driven by the usage of sensors, digital technologies, and wearables, thereby allowing the healthcare personnel to delve deep into the patients’ live – be it pre-operative, post-operative, or the period in between. Consumer tech companies are into making caregivers visible outside of the clinical environment a reality. Ineffective esophageal
The Ineffective Esophageal Motility Treatment Market to Adopt Digitization
The Ineffective Esophageal Motility Treatment Market is there to witness remarkable growth in the forecast period. The existing scenario implies the consumerization of healthcare. In other words, technology is relieving the hospital staff from providing an appropriate level of the care needed, that too, in a better way. Data-driven diagnosis has seen the light of the day in wake of habits and requirements of smartphone-oriented patients. This would be the
IAS Questions MoH Push for Ineffective Vaccine
The Immunisation Awareness Society is raising concern about the inadequate level of information provided to the public regarding the whooping cough vaccine. Auckland, New Zealand, April 11, 2012 -- GIVEN the current push by the Ministry of Health (MoH) for people to get their whooping cough (pertussis) vaccinations, the Immunisation Awareness Society (IAS) is raising concerns about the inadequate level of information provided around vaccination in New Zealand. The latest figures from